Loading stock data…
Zimmer Biomet Holdings, Inc. (ZBH)
$93.10+2.14 (+2.35%)
Market ClosedLast close Jun 26
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Zimmer Biomet Holdings, Inc. in the Healthcare sector is trading at $93.10 with a market capitalization of $16.4B. Wall Street consensus targets $98.70 (20 analysts), implying a +6.0% move over the next 12 months. The stock is currently 14% below its 52-week high of $108.29, remaining 1.6% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +6.0% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.09B↓ | $2.24B↑ | $2.00B↓ | $2.08B↑ | $1.91B |
| Gross Profit | $1.51B↑ | $1.45B↑ | $1.44B↓ | $1.49B↑ | $1.36B |
| Operating Income | $395.10M↑ | $282.60M↓ | $338.30M↓ | $396.40M↑ | $338.90M |
| Net Income | $238.10M↑ | $139.30M↓ | $230.90M↑ | $152.80M↓ | $182.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, inclu...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$16.44B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.02
Beta
Defensive asset. Lower volatility than the S&P 500.
0.47
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.03%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.01%
Volume
Today's trading volume
2.14M
Recent News
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.
The Cash-Flow Fortress The Stryker Stock Bears Keep Missing
While the market fixates on a disruptive quarter for Stryker stock, the company's powerful ability to convert profit into hard cash reveals a deeper, under-appreciated resilience.
Insulet Corporation Stock: Is PODD Underperforming the Healthcare Sector?
Insulet Corporation has underperformed the healthcare sector over the past year. However, analysts remain strongly bullish about its prospects.
Is Zimmer Biomet Stock Underperforming the S&P 500?
Zimmer Biomet has lagged the broader S&P 500 Index over the past year, and analysts remain on the sidelines as they weigh the company's steady fundamentals against its modest growth outlook.
Is Solventum Corporation (SOLV) A Good Stock To Buy Now?
Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV. Solventum Corporation’s share was trading at $82.46 as of June 9th. SOLV’s trailing and forward P/E were 10.09 and 12.58 respectively according to Yahoo Finance. Solventum […]